Erica L Jackson

6PUBLICATIONS
63CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 04, 2025
STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20-Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer Models.

Raymond A Pagliarini, Jack A Henderson, Benjamin C Milgram

|Aug 23, 2024
ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors.

Christopher T Chen, Vishesh Khanna, Shivaani Kummar

|Sep 15, 2023
Precision Oncology Comes of Age: Designing Best-in-Class Small Molecules by Integrating Two Decades of Advances in Chemistry, Target Biology, and Data Science.

Darrin D Stuart, Angel Guzman-Perez, Natasja Brooijmans

|Aug 25, 2023
STX-478, a Mutant-Selective, Allosteric PI3Kα Inhibitor Spares Metabolic Dysfunction and Improves Therapeutic Response in PI3Kα-Mutant Xenografts.

Leonard Buckbinder, David J St Jean, Trang Tieu

|Aug 19, 2022
EHMT2 methyltransferase governs cell identity in the lung and is required for KRAS G12D tumor development and propagation.

Ariel Pribluda, Anneleen Daemen, Anthony Nelson Lima

|May 31, 2019
NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinoma.

Ganapati V Hegde, Cecile de la Cruz, Jennifer M Giltnane

Pageof 1

Frequent Collaborators

3 joint publications

Angel Guzman-Perez

3 joint publications

Darrin D Stuart

3 joint publications

Natasja Brooijmans

3 joint publications

Gregory V Kryukov